Evidence map›Paper›PMID 41010690›Full record

ArticleJournal of clinical medicine2025

Clinical Burden of People with Symptomatic and Exacerbating COPD While on Triple Inhaled Therapy.

Anthony De Soyza, Clementine Nordon, Emily Coak, Tia Pennant, Hana Mullerova, Malin Fageras, João Andre Alves, Wim Janssens

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anthony De SoyzaPopulation and Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle NE2 4HH, UK.ORCID 0000-0002-8566-0344
Clementine NordonGlobal Medical Evidence, AstraZeneca, Cambridge CB2 0AA, UK.
Emily CoakAdelphi Real World, Bollington SK10 5JB, UK.
Tia PennantAdelphi Real World, Bollington SK10 5JB, UK.
Hana MullerovaGlobal Medical Evidence, AstraZeneca, Cambridge CB2 0AA, UK.
Malin FagerasGlobal Medical Affairs, AstraZeneca, 43183 Gothenburg, Sweden.
João Andre AlvesGlobal Medical Affairs, AstraZeneca, 43183 Gothenburg, Sweden.
Wim JanssensDepartment of Respiratory Diseases, University Hospital Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-1830-2982

Funding

AstraZeneca
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic obstructive pulmonary diseasedisease burdenexacerbationstriple inhaled therapy

Identifiers

PMID41010690
PMCPMC12470491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.